Abstract
Two major forces impacting the ability to deliver health care services, products, and information are in a significant period of transition in the United States. Specifically, health care reform and the growing cultural diversity of the patient population will require health care professionals to analyze the traditional strategies and tactics used in accomplishing objectives.
The pharmaceutical industry, in particular, should include minority health initiatives in all phases of product development and marketing. This will insure adherence to pending legal/regulatory requirements as well as target the needs of the most rapidly growing segment of the American population.
There are a multitude of available opportunities for industry to partner with government, medical societies, managed care organizations, and so forth in order to accomplish mutually beneficial objectives. The end result will be a positive impact on closing health care “gaps” currently existing with minority populations and an increased product use rate.
Get full access to this article
View all access options for this article.